STADA received the CHi Award for Business Development Team of the Year 2021

  • 07/03/2021

Stada captures the OTCToolbox Consumer Healthcare Industry (CHi) Award for Business Development Team of the Year thanks to a series of significant deals. Judges said Stada had been “truly aggressive”.

Stada’s business development team accomplished a lot in 2020. The German generics and OTC company completed a number of big acquisitions involving European consumer healthcare assets that had been announced towards the end of 2019. Furthermore, it unveiled new acquisitions, partnerships and licensing deals around the world

In March 2020, Stada completed the purchase of Czech firm Walmark from private-equity firm Mid Europa Partners for an undisclosed sum.

In the same month, Stada also completed the acquisition of a portfolio of OTC and prescription products from Japan’s Takeda in Russia and the Commonwealth of Independent States (CIS) in a deal worth USD660 million

Stada also completed the acquisition of the pharmaceutical and consumer healthcare business of Ukrainian company Biopharma, including its Biosporin and Subalin probiotic products.

Furthermore, it announced that it was strengthening its consumer healthcare presence in Europe by acquiring 15 brands – including Venoruton, Coldrex and Cetebe – from GlaxoSmithKline (GSK).

In addition to completing these European deals, Stada unveiled a number of acquisitions, alliances and licensing deals around the world.

Commenting on the OTCToolbox CHi Award, Peter Goldschmidt, Stada’s chief executive officer, said the company was “delighted” to be Business Development Team of the Year. “This is a recognition of Stada’s ambition to become a consumer healthcare leader in Europe and increasingly in regions such as the Middle East, Asia-Pacific and the US,” he added. “Stada continues to seek further opportunities to augment the group’s inorganic expansion of consumer healthcare through further partnerships and acquisitions, particularly for local hero brands. On top of this we are driving the internationalisation of our own strong brands.”

Comments from the judges

Seven of the 10 judges for the OTCToolbox CHi Award for Business Development Team of the Year ranked Stada first out of the nine candidates. A further two placed it second.

Bob Moran of Plexus Ventures said Stada had been “truly aggressive in growing the company’s portfolio and geographic reach”.

Fuad Sawaya of Sawaya Partners said Stada had an “impressive cadence of completed deals in multiple geographies” and was “one of the best oiled M&A machines in the industry”.

Mathias Käsebier of Bannert Manlik Consultants said Stada’s focus on local brand heroes allowed the company to acquire iconic brands from leading consumer healthcare companies as they streamlined portfolios.

Peter Burrows also highlighted that Stada was acquiring “trusted consumer brands”.

Andy Tisman said that Stada had completed several significant transactions in 2020 which had contributed to an ongoing transformation of the business. “The Walmark, Takeda and Biopharma acquisitions very significantly strengthen Stada’s position in Central and Eastern Europe,” he noted, “while several other transactions reinforce Stada’s position in Europe and Asia-Pacific.”